Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 50742-331

11 FDA label images from Ingenus Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 50742-331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure of pramipexole dihydrochloride monohydrate showing the molecular arrangement including its amine, thiazole, and cyclohexane components with hydrochloride and water molecules.*
FDA Label Image

Image-11 (Image 11)

FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A data table presenting the imprints on extended-release Pramipexole dihydrochloride tablets by Ingenus Pharmaceuticals, LLC for strengths 0.375 mg through 4.5 mg. The front imprint shows the tablet strength (e.g., '0.375', '0.75', '1.5'), while the back imprint displays codes from 'P11' to 'P17' corresponding with increasing strengths.*
FDA Label Image

Image-10 (Image 10)

FDA Label Image

0.375-mg (0.375 mg)

0.375-mg (0.375 mg)
Label for Pramipexole Dihydrochloride Extended-Release Tablets, 0.375 mg strength, manufactured by Ingenus Pharmaceuticals, LLC. The label specifies the dosage form as extended-release tablets intended for once daily oral use, with a 30-tablet count. It includes storage instructions, dosage directions, and child safety warnings, along with the product NDC 50742-331-30.*
FDA Label Image

0.75-mg (0.75 mg)

0.75-mg (0.75 mg)
Pramipexole dihydrochloride extended-release tablets, 0.75 mg strength, oral dosage form, supplied in a container of 30 tablets. The label shows the product is manufactured by Ingenus Pharmaceuticals, LLC with NDC 50742-332-30. It includes dosing instructions emphasizing swallowing whole without chewing or crushing. Storage conditions specify 20° to 25°C. The label has barcodes and placeholders for lot, expiration, and serial numbers.*
FDA Label Image

1.5-mg (1.5 mg)

1.5-mg (1.5 mg)
Label for Pramipexole Dihydrochloride Extended-Release Tablets 1.5 mg by Ingenus Pharmaceuticals, LLC. The label states "Once Daily" dosing and includes storage instructions. The package contains 30 tablets and features detailed drug information, barcode, lot, expiration, and serial numbers.*
FDA Label Image

2.25-mg (2.25 mg)

2.25-mg (2.25 mg)
Label for Pramipexole Dihydrochloride Extended-Release Tablets 2.25 mg by Ingenus Pharmaceuticals, LLC. The label states 'Once Daily' dosing and contains 30 tablets. It includes storage instructions, dosage warnings, and barcode information. Manufactured for Ingenus Pharmaceuticals, LLC in Orlando, FL, with NDC 50742-334-30.*
FDA Label Image

3-mg (3 mg)

3-mg (3 mg)
Label for Pramipexole Dihydrochloride Extended-Release Tablets 3 mg, once daily, containing 30 tablets. Manufactured by Ingenus Pharmaceuticals, LLC. The label includes dosage instructions, storage recommendations, barcodes, and lot, expiration, and serial number placeholders. It specifies tablets must be swallowed whole and kept out of reach of children.*
FDA Label Image

3.75-mg (3.75 mg)

3.75-mg (3.75 mg)
Label for Pramipexole Dihydrochloride Extended-Release Tablets, 3.75 mg strength, manufactured by Ingenus Pharmaceuticals, LLC. The label indicates a 30-tablet prescription package with dosing instructions to swallow tablets whole once daily. Storage instructions and lot, expiration, and serial number placeholders are visible.*
FDA Label Image

4.5-mg (4.5 mg)

4.5-mg (4.5 mg)
Label for Pramipexole Dihydrochloride Extended-Release Tablets, 4.5 mg strength, by Ingenus Pharmaceuticals, LLC. The label states the dosage form as extended-release tablets, oral route, with a 30 tablet count. It includes storage instructions, barcode, lot, expiration, and serial numbers space, and dosage directions indicating to swallow whole without chewing or crushing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.